Background: Gynaecological tumours in women found as the main cause of morbidity and mortality. Gynaecological tumours are of various type out of which endometrium and ovary are the most common. Aim and Objective: To study the different clinical symptoms of gynaecological tumours. Material and Methods: The present observational study was conducted in the Department of Radiation Oncology, Lady Hardinge Medical College and SSKM Hospital, New Delhi from January 2023 to January 2024 on 50 patients for a period of one year who were referred from the Obstetrics and Gynaecology department of the hospital. Results: Mean age of patients was 48.24±13.24 years. Majority of women had normal vaginal delivery i.e. 32(64%) followed by 18(36%) who underwent LSCS, 19(38%) women used different types of contraceptive methods available. Abdominal pain observed in 20(40%), post menopausal bleeding in 10(20%), amenorrhea in 2(4%) and abdominal distension in 3(6%). In majority of women endometrium tumour found to be the most common i.e. 25(50%) followed by Ovarian cancer i.e. 22(44%). In 9(18%) cervix tumour, vulvar tumour was in 1(2%), vaginal tumour in 2(4%) and fallopian tube tumour was in 1(2%) women found, In majority of women endometrium tumour found to be the most common i.e. 25(50%) followed by Ovarian cancer i.e. 22(44%). In 9(18%) cervix tumour, vulvar tumour was in 1(2%), vaginal tumour in 2(4%) and fallopian tube tumour was in 1(2%) women found. In women having cervix cancer, abdominal pain was in 2(4%), postmenopausal bleeding in 3(6%) and mass per abdomen in 1(2%) women observed. Postmenopausal bleeding (PMB) reported in 13(25%) women with endometrium cancer. Pain abdomen in women having ovarian cancer i.e. 6(12%), mass per abdomen 4(8%), abnormal bleeding per vagium in 2(4%). In women having vulvar, vagina and fallopian tube cancer present study found 1(2%), 2(4%) and 1(2%), women respectively. A total of 22(44%) patients were treated surgically and 28(56%) by radiotherapy. Conclusion: In the present study, endometrium cancer and ovarian cancer found to be the most common followed by cervical, vulvar, vaginal and fallopian tube. Our study showed that most of women attended the hospital at an advance stage of the disease. So, therefore, it is not possible for the attending physician to early detect and diagnose the disease to reduce morbidity and mortality. It is also seen that in developing countries maximum number of women with tumours presented at advance stage due to this timely screening, early diagnosis and treatment modalities is not effective to keep the fertility and decrease mortality. Present study recommends that educational as well as general population awareness programme particularly in women of developing countries like ours. Further, urgent need on healthcare programs is a necessary step to increase the screening methods of premalignant lesions in younger population at primary healthcare institutions particularly in rural areas as well as in urban plays a significant role to early detect the patients followed by treatment.